Genetic variants related to angiogenesis and apoptosis in patients with glioma

ABSTRACT Background Glioma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. The objectives of this study were to evaluate the association of genetic polymorphisms related to angiogenesis and apoptosis with gliomas, as well as comorbidities, lifestyle, clinical profile, survival and response to treatment (temozolomide [TMZ] and radiotherapy [RT]) in patients with the disease. Methods In a total of 303 individuals, genotypes were performed by real-time PCR, and clinical data, lifestyle and comorbidities were obtained from medical records and questionnaires. The significance level was set at 5%. Results Smoking, alcohol consumption, systemic arterial hypertension, diabetes mellitus and body mass index prevailed among patients, compared to controls (p < 0.05). The heterozygous genotype rs1468727 (T/C) and the homozygous genotype rs2010963 (G/G) (p > 0.05) were observed in both groups. Lifestyle and comorbidities showed independent risk factors for the disease (p < 0.0001, p = 0.0069, p = 0.0394, respectively). Patients with low-grade gliomas had a survival rate of 80.0 ± 1.7% in three years. For the combination of TMZ+RT, survival was 78.7 ± 7.6% in 20 months, compared to TMZ only (21.9 ± 5.1%, p = 0.8711). Conclusions Genetic variants were not associated with gliomas. Specific lifestyle habits and comorbidities stood out as independent risk factors for the disease. Low-grade gliomas showed an increase in patient survival with TMZ+RT treatment.

Saved in:
Bibliographic Details
Main Authors: Calastri,Maria Clara Jessica, Rodrigues,Nicolas Luz Toledo Ortega, Hatori,Gabriela, Gregório,Michele Lima, Brancati,Camila Ive Ferreira Oliveira, Zanovelo,Eliane Milharcix, Ferraz Filho,José Roberto Lopes, Neiva,Cassiano Merussi, Rodrigues Junior,Antonio Carlos Ponde, Godoy,Moacir Fernandes de, Lancelloti,Carmen Lucia Penteado, Tognola,Waldir Antonio, Souza,Dorotéia Rossi Silva
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000600393
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-282X2018000600393
record_format ojs
spelling oai:scielo:S0004-282X20180006003932018-06-26Genetic variants related to angiogenesis and apoptosis in patients with gliomaCalastri,Maria Clara JessicaRodrigues,Nicolas Luz Toledo OrtegaHatori,GabrielaGregório,Michele LimaBrancati,Camila Ive Ferreira OliveiraZanovelo,Eliane MilharcixFerraz Filho,José Roberto LopesNeiva,Cassiano MerussiRodrigues Junior,Antonio Carlos PondeGodoy,Moacir Fernandes deLancelloti,Carmen Lucia PenteadoTognola,Waldir AntonioSouza,Dorotéia Rossi Silva central nervous system genes, erbB-1 glioblastoma ABSTRACT Background Glioma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. The objectives of this study were to evaluate the association of genetic polymorphisms related to angiogenesis and apoptosis with gliomas, as well as comorbidities, lifestyle, clinical profile, survival and response to treatment (temozolomide [TMZ] and radiotherapy [RT]) in patients with the disease. Methods In a total of 303 individuals, genotypes were performed by real-time PCR, and clinical data, lifestyle and comorbidities were obtained from medical records and questionnaires. The significance level was set at 5%. Results Smoking, alcohol consumption, systemic arterial hypertension, diabetes mellitus and body mass index prevailed among patients, compared to controls (p < 0.05). The heterozygous genotype rs1468727 (T/C) and the homozygous genotype rs2010963 (G/G) (p > 0.05) were observed in both groups. Lifestyle and comorbidities showed independent risk factors for the disease (p < 0.0001, p = 0.0069, p = 0.0394, respectively). Patients with low-grade gliomas had a survival rate of 80.0 ± 1.7% in three years. For the combination of TMZ+RT, survival was 78.7 ± 7.6% in 20 months, compared to TMZ only (21.9 ± 5.1%, p = 0.8711). Conclusions Genetic variants were not associated with gliomas. Specific lifestyle habits and comorbidities stood out as independent risk factors for the disease. Low-grade gliomas showed an increase in patient survival with TMZ+RT treatment.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.76 n.6 20182018-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000600393en10.1590/0004-282x20180051
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Calastri,Maria Clara Jessica
Rodrigues,Nicolas Luz Toledo Ortega
Hatori,Gabriela
Gregório,Michele Lima
Brancati,Camila Ive Ferreira Oliveira
Zanovelo,Eliane Milharcix
Ferraz Filho,José Roberto Lopes
Neiva,Cassiano Merussi
Rodrigues Junior,Antonio Carlos Ponde
Godoy,Moacir Fernandes de
Lancelloti,Carmen Lucia Penteado
Tognola,Waldir Antonio
Souza,Dorotéia Rossi Silva
spellingShingle Calastri,Maria Clara Jessica
Rodrigues,Nicolas Luz Toledo Ortega
Hatori,Gabriela
Gregório,Michele Lima
Brancati,Camila Ive Ferreira Oliveira
Zanovelo,Eliane Milharcix
Ferraz Filho,José Roberto Lopes
Neiva,Cassiano Merussi
Rodrigues Junior,Antonio Carlos Ponde
Godoy,Moacir Fernandes de
Lancelloti,Carmen Lucia Penteado
Tognola,Waldir Antonio
Souza,Dorotéia Rossi Silva
Genetic variants related to angiogenesis and apoptosis in patients with glioma
author_facet Calastri,Maria Clara Jessica
Rodrigues,Nicolas Luz Toledo Ortega
Hatori,Gabriela
Gregório,Michele Lima
Brancati,Camila Ive Ferreira Oliveira
Zanovelo,Eliane Milharcix
Ferraz Filho,José Roberto Lopes
Neiva,Cassiano Merussi
Rodrigues Junior,Antonio Carlos Ponde
Godoy,Moacir Fernandes de
Lancelloti,Carmen Lucia Penteado
Tognola,Waldir Antonio
Souza,Dorotéia Rossi Silva
author_sort Calastri,Maria Clara Jessica
title Genetic variants related to angiogenesis and apoptosis in patients with glioma
title_short Genetic variants related to angiogenesis and apoptosis in patients with glioma
title_full Genetic variants related to angiogenesis and apoptosis in patients with glioma
title_fullStr Genetic variants related to angiogenesis and apoptosis in patients with glioma
title_full_unstemmed Genetic variants related to angiogenesis and apoptosis in patients with glioma
title_sort genetic variants related to angiogenesis and apoptosis in patients with glioma
description ABSTRACT Background Glioma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. The objectives of this study were to evaluate the association of genetic polymorphisms related to angiogenesis and apoptosis with gliomas, as well as comorbidities, lifestyle, clinical profile, survival and response to treatment (temozolomide [TMZ] and radiotherapy [RT]) in patients with the disease. Methods In a total of 303 individuals, genotypes were performed by real-time PCR, and clinical data, lifestyle and comorbidities were obtained from medical records and questionnaires. The significance level was set at 5%. Results Smoking, alcohol consumption, systemic arterial hypertension, diabetes mellitus and body mass index prevailed among patients, compared to controls (p < 0.05). The heterozygous genotype rs1468727 (T/C) and the homozygous genotype rs2010963 (G/G) (p > 0.05) were observed in both groups. Lifestyle and comorbidities showed independent risk factors for the disease (p < 0.0001, p = 0.0069, p = 0.0394, respectively). Patients with low-grade gliomas had a survival rate of 80.0 ± 1.7% in three years. For the combination of TMZ+RT, survival was 78.7 ± 7.6% in 20 months, compared to TMZ only (21.9 ± 5.1%, p = 0.8711). Conclusions Genetic variants were not associated with gliomas. Specific lifestyle habits and comorbidities stood out as independent risk factors for the disease. Low-grade gliomas showed an increase in patient survival with TMZ+RT treatment.
publisher Academia Brasileira de Neurologia - ABNEURO
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000600393
work_keys_str_mv AT calastrimariaclarajessica geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT rodriguesnicolasluztoledoortega geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT hatorigabriela geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT gregoriomichelelima geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT brancaticamilaiveferreiraoliveira geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT zanoveloelianemilharcix geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT ferrazfilhojoserobertolopes geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT neivacassianomerussi geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT rodriguesjuniorantoniocarlosponde geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT godoymoacirfernandesde geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT lancelloticarmenluciapenteado geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT tognolawaldirantonio geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
AT souzadoroteiarossisilva geneticvariantsrelatedtoangiogenesisandapoptosisinpatientswithglioma
_version_ 1756374750266916864